These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3131837

  • 21. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    Imai T, Vercellotti GM, Moldow CF, Jacob HS, Weir EK.
    J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
    [Abstract] [Full Text] [Related]

  • 22. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J, Rotilio D, Vargaftig BB.
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [Abstract] [Full Text] [Related]

  • 23. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
    [Abstract] [Full Text] [Related]

  • 24. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK, Mais DE, Halushka PV.
    Biochim Biophys Acta; 1994 Mar 10; 1221(1):83-8. PubMed ID: 8130280
    [Abstract] [Full Text] [Related]

  • 25. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL, Darius H, Lefer AM.
    Life Sci; 1986 Jun 02; 38(22):2037-41. PubMed ID: 2940431
    [Abstract] [Full Text] [Related]

  • 26. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC.
    Biochem Pharmacol; 1996 Sep 13; 52(5):763-70. PubMed ID: 8765474
    [Abstract] [Full Text] [Related]

  • 27. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
    Schumacher WA, Steinbacher TE.
    J Lipid Mediat; 1991 Sep 13; 4(1):97-110. PubMed ID: 1832573
    [Abstract] [Full Text] [Related]

  • 28. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M, Mais DE, Morinelli TA, Hamanaka N, Oatis JE, Halushka PV.
    J Pharmacol Exp Ther; 1992 Aug 13; 262(2):632-7. PubMed ID: 1386885
    [Abstract] [Full Text] [Related]

  • 29. Effect of thromboxane A2/endoperoxide antagonist SQ29548 on the contractile response to acetylcholine in newborn piglet cerebral arteries.
    Wagerle LC, Busija DW.
    Circ Res; 1990 Mar 13; 66(3):824-31. PubMed ID: 2306808
    [Abstract] [Full Text] [Related]

  • 30. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
    Becker K, Lueddeckens G, Grupe R, Förster W.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar 13; 48(3):265-71. PubMed ID: 8385779
    [Abstract] [Full Text] [Related]

  • 31. Thromboxane A2 mimetic U46619 stimulates ciliary motility of rabbit tracheal epithelial cells.
    Chiyotani A, Tamaoki J, Sakai N, Isono K, Kondo M, Konno K.
    Prostaglandins; 1992 Feb 13; 43(2):111-20. PubMed ID: 1311864
    [Abstract] [Full Text] [Related]

  • 32. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar 13; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 33. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
    Shin Y, Romstedt KJ, Doyle K, Harrold MW, Gerhardt MA, Miller DD, Patil PN, Feller DR.
    Chirality; 1991 Jul 01; 3(2):112-7. PubMed ID: 1830752
    [Abstract] [Full Text] [Related]

  • 38. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
    Ishizuka T, Suzuki K, Kawakami M, Hidaka T, Matsuki Y, Nakamura H.
    Eur J Pharmacol; 1996 Oct 03; 312(3):367-77. PubMed ID: 8894620
    [Abstract] [Full Text] [Related]

  • 39. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV, Slotman GJ.
    Crit Care Med; 1999 Nov 03; 27(11):2485-94. PubMed ID: 10579269
    [Abstract] [Full Text] [Related]

  • 40. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ, Thiemermann C, Vane JR.
    Br J Pharmacol; 1995 Dec 03; 116(8):3191-8. PubMed ID: 8719795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.